Moderate to severe ulcerative colitis
Clinical trials for Moderate to severe ulcerative colitis explained in plain language.
Never miss a new study
Get alerted when new Moderate to severe ulcerative colitis trials appear
Sign up with your email to follow new studies for Moderate to severe ulcerative colitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug vixarelimab tested for Tough-to-Treat ulcerative colitis
Disease control CompletedThis early-stage trial is testing a drug called vixarelimab in 24 people with moderate to severe ulcerative colitis who have not improved with standard treatments. The study looks at how the drug affects the gut, how it moves through the body, and whether it is safe. It is too ea…
Matched conditions: MODERATE TO SEVERE ULCERATIVE COLITIS
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Sep 21, 2026 13:01 UTC
-
New drug shows promise for ulcerative colitis sufferers
Disease control CompletedThis study tested a new drug called PF-06480605 in 246 adults with moderate to severe ulcerative colitis. Participants received different doses of the drug or a placebo for 12 weeks, then everyone received the active drug for 40 more weeks. The goal was to see if the drug could h…
Matched conditions: MODERATE TO SEVERE ULCERATIVE COLITIS
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC